InvestorsHub Logo
icon url

bas2020

01/23/24 2:27 PM

#448913 RE: Investor2014 #448911

Excellence was properly placed in the chart being a Ph 2/3 trial. The review of the basket of results by the RAs may very well make it pivotal and approvable for both adult and pediatric patients.